# Allosteros Therapeutics Inc. — Form D

Allosteros Therapeutics Inc. of Palo Alto, X1, a company, filed a Form D exempt-offering notice with the SEC on 2012-08-24. The offering totals $286K, of which $286K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2012-08-24
- Form: D
- Accession: 0001503753-12-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $286K
- Amount sold: $286K
- Investors: 1
- Security types: debt
- Revenue range: Decline to Disclose

## Issuer

- Name: Allosteros Therapeutics Inc.
- CIK: 0001503753
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 560 PENA COURT, Palo Alto, X1, 94306
- Phone: 650-644-7559

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Mark Anderson | Director | San Mateo, CA |
| Howard Schulman | Director | Palo Alto, CA |
| Howard Schulman | Executive Officer | Palo Alto, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2010-10-18](https://search.stillhousedata.com/formd/0001503753-10-000001) | D | $1.0M | $1.0M |

## More

- [CIK 1503753 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1503753&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001503753-12-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.